Evidence map›Paper›PMID 32467628›Full record

ArticleEye (London, England)2021

Prospective deep phenotyping of choroideremia patients using multimodal structure-function approaches.

Ahmed M Hagag, Andreas Mitsios, Akshay Narayan, Alessandro Abbouda, Andrew R Webster, Adam M Dubis, Mariya Moosajee

Open access · hybridAbstract read
In one paragraph

Article in Eye (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Exploring Scotopic Microperimetry as an Outcome Measure in Choroideremia.Translational vision science & technology · 2024
    Article
  6. Loss of REP1 impacts choroidal melanogenesis and vasculogenesis in choroideremia.Biochimica et biophysica acta. Molecular basis of disease · 2024
    Article
  7. Choroideremia: The Endpoint Endgame.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.Investigative ophthalmology & visual science · 2022
    Article
  10. The Natural History ofInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ahmed M HagagMoorfields Eye Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-3372-7885
Andreas MitsiosMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Akshay NarayanUCL Institute of Ophthalmology, London, UK.
Alessandro AbboudaMoorfields Eye Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0001-8582-4823
Andrew R WebsterMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Adam M DubisMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Mariya MoosajeeMoorfields Eye Hospital NHS Foundation Trust, London, UK. m.moosajee@ucl.ac.uk.ORCID http://orcid.org/0000-0003-1688-5360
Moorfields Eye Hospital NHS Foundation Trust · GBUniversity College London · GB

Funding

Wellcome Trust 205174/Z/16/ZWellcome Trust (Wellcome) 205174/Z/16/Z
6 · The paper itself

Abstract

objectiveTo investigate the retinal changes in choroideremia (CHM) patients to determine correlations between age, structure and function. SUBJECTS/

methodsTwenty-six eyes from 13 male CHM patients were included in this prospective longitudinal study. Participants were divided into <50-year (n = 8) and ≥50-year (n = 5) old groups. Patients were seen at baseline, 6-month, and 1-year visits. Optical coherence tomography (OCT), OCT angiography, and fundus autofluorescence were performed to measure central foveal (CFT) and subfoveal choroidal thickness (SCT), as well as areas of preserved choriocapillaris (CC), ellipsoid zone (EZ), and autofluorescence (PAF). Patients also underwent functional investigations including visual acuity (VA), contrast sensitivity (CS), colour testing, microperimetry, dark adaptometry, and handheld electroretinogram (ERG). Vision-related quality-of-life was assessed by using the NEI-VFQ-25 questionnaire.

resultsOver the 1-year follow-up period, progressive loss was detected in SCT, EZ, CC, PAF, and CFT. Those ≥50-years exhibited more structural and functional defects with SCT, EZ, CC, and PAF showing strong correlation with patient age (rho ≤ -0.47, p ≤ 0.02). CS and VA did not change over the year, but CS was significantly correlated with age (rho = -0.63, p = 0.001). Delayed to unmeasurable dark adaptation, decreased colour discrimination and no detectable ERG activity were observed in all patients. Minimal functional deterioration was observed over one year with a general trend of slower progression in the ≥50-years group.

conclusionsQuantitative structural parameters including SCT, CC, EZ, and PAF are most useful for disease monitoring in CHM. Extended follow-up studies are required to determine longitudinal functional changes.

Indexed as

ChoroideremiaChoroidFluorescein AngiographyHumansLongitudinal StudiesMaleProspective StudiesTomography, Optical Coherence

Identifiers

PMID32467628
PMCPMC8027673
OpenAlexW3029250325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.